Episode Details

Back to Episodes
Episode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)

Episode 462: April 2025 Retinal Physician Preview Focusing on Current and Future Therapies for Neovascular AMD (and a Mention of Biosimilars for Uveitis)

Published 1 year, 2 months ago
Description

Drs. Akshay Thomas and Priya Vakharia join to preview the April 2025 edition of Retinal Physician, focusing on current and future therapies for neovascular AMD.

Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech, Regeneron, and Eyepoint. Dr. Vakharia has consulted for Regeneron, Ocular Therapeutix, and Eyepoint.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us